Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,977 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.
Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GY, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G. Kirchhof P, et al. Among authors: lip gy. Europace. 2007 Nov;9(11):1006-23. doi: 10.1093/europace/eum191. Epub 2007 Sep 25. Europace. 2007. PMID: 17897925
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
Meinertz T, Lip GY, Lombardi F, Sadowski ZP, Kalsch B, Camez A, Hewkin A, Eberle S; ERAFT Investigators. Meinertz T, et al. Among authors: lip gy. Am J Cardiol. 2002 Dec 15;90(12):1300-6. doi: 10.1016/s0002-9149(02)02867-9. Am J Cardiol. 2002. PMID: 12480038 Clinical Trial.
Antithrombotic treatment in atrial fibrillation.
Lip GY, Boos CJ. Lip GY, et al. Heart. 2006 Feb;92(2):155-61. doi: 10.1136/hrt.2005.066944. Epub 2005 Sep 13. Heart. 2006. PMID: 16159980 Free PMC article. Review.
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ; Euro Heart Survey Investigators. Nieuwlaat R, et al. Among authors: lip gy. Am Heart J. 2007 Jun;153(6):1006-12. doi: 10.1016/j.ahj.2007.03.008. Am Heart J. 2007. PMID: 17540203
Outcome parameters for trials in atrial fibrillation: executive summary.
Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GY, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G. Kirchhof P, et al. Among authors: lip gy. Eur Heart J. 2007 Nov;28(22):2803-17. doi: 10.1093/eurheartj/ehm358. Epub 2007 Sep 25. Eur Heart J. 2007. PMID: 17897924
Interleukin-8 and atrial fibrillation.
Melenovsky V, Lip GY. Melenovsky V, et al. Among authors: lip gy. Europace. 2008 Jul;10(7):784-5. doi: 10.1093/europace/eun154. Epub 2008 Jun 3. Europace. 2008. PMID: 18523030 No abstract available.
Quality of life in older people with atrial fibrillation.
Lane DA, Lip GY. Lane DA, et al. Among authors: lip gy. J Interv Card Electrophysiol. 2009 Jun;25(1):37-42. doi: 10.1007/s10840-008-9318-y. Epub 2008 Nov 26. J Interv Card Electrophysiol. 2009. PMID: 19034639 Review.
3,977 results